Hawthorne Health and RxE2 Partner to Transform Community-Based Clinical Trial Delivery Hawthorne Health, a leader in community-based clinical trial delivery, and RxE2, a pioneer in pharmacist-led clinical trial services, have announced a groundbreaking strategic partnership aimed at revolutionizing the way…
Quanta System, a leader in medical laser technology, is celebrating a significant milestone in 2025: its 40th anniversary. This momentous occasion not only honors the company’s rich history of technological advancements and breakthroughs but also marks the start of an…
Kyowa Kirin and Swixx BioPharma Expand Access to POTELIGEO® for Mycosis Fungoides and Sézary Syndrome in Central and Eastern Europe Kyowa Kirin International (KKI), a fully owned subsidiary of Kyowa Kirin Co. Ltd., in partnership with Swixx BioPharma AG, recently…
Tubulis Advances ADC TUB-030 into Clinical Trials for Advanced Solid Tumors Tubulis, a biopharmaceutical company focused on antibody-drug conjugates (ADCs), announced a significant milestone today with the dosing of the first patient in its Phase I/IIa clinical trial, 5-STAR 1-01…
Osta Therapeutics Expands Leadership Team with Two Industry Experts to Combat Antibiotic Resistance Osta Therapeutics Expands Leadership Team to Tackle Antibiotic Resistance Osta Therapeutics, a biotechnology company focused on developing innovative treatments to combat antibiotic resistance, has announced the appointment…
Ethris Announces Promising Phase 1 Clinical Data for mRNA Therapeutic ETH47 in Asthma Treatment Ethris GmbH, a biotechnology pioneer in the development of next-generation RNA therapeutics and vaccines, has announced promising topline results from its completed Phase 1 clinical trial…
Merz Aesthetics Reveals Global Data on the Link Between Self-Confidence, Self-Affirmation, and Aesthetic Treatments Merz Aesthetics, the world’s largest company in aesthetic medicine, has unveiled the findings of its first global study, “Pillars of Confidence: Global Insights on Aesthetics and…
Owkin, a pioneering AI-biotech company dedicated to transforming drug discovery, development, and diagnostics through agentic AI, has announced the dosing of the first patient in its Phase I clinical trial of OKN4395. The trial commenced on January 22, 2025, and…
Ferrer Earns Compliance Leader Verification™ for Exemplary Ethical and Responsible Corporate Practices Ferrer, a globally recognized pharmaceutical company, has been awarded the prestigious Compliance Leader Verification™ by Ethisphere, an organization dedicated to promoting ethical business practices worldwide. This recognition underscores…
Takeda (TOKYO:4502/NYSE:TAK) has announced its third-quarter earnings results for fiscal year 2024, reporting significant progress in its Growth & Launch Products. These products experienced robust growth, posting a 14.6% increase at constant exchange rates (CER). The company has upgraded its…
Galderma, a global leader in dermatology, is pioneering research into the effects of medication-driven weight loss on the skin and the importance of incorporating aesthetic treatments into the patient journey. As the prevalence of prescription weight loss medications grows, with…
Virpax Pharmaceuticals Announces Public Offering Pricing to Fuel Drug Development and Innovation Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX), a forward-thinking preclinical-stage pharmaceutical company specializing in groundbreaking drug delivery systems for pain management, has unveiled the pricing details of its latest public…
